A detailed history of Financial Management Professionals, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Financial Management Professionals, Inc. holds 676 shares of AZN stock, worth $48,279. This represents 0.01% of its overall portfolio holdings.

Number of Shares
676
Previous 589 14.77%
Holding current value
$48,279
Previous $46,000 15.22%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$76.67 - $87.62 $6,670 - $7,622
87 Added 14.77%
676 $53,000
Q2 2024

Jul 12, 2024

BUY
$66.81 - $80.83 $1,670 - $2,020
25 Added 4.43%
589 $46,000
Q1 2024

Apr 16, 2024

BUY
$61.03 - $69.57 $2,013 - $2,295
33 Added 6.21%
564 $38,000
Q4 2023

Jan 12, 2024

BUY
$61.89 - $69.28 $1,423 - $1,593
23 Added 4.53%
531 $36,000
Q3 2023

Oct 13, 2023

SELL
$64.85 - $71.7 $518 - $573
-8 Reduced 1.55%
508 $34,000
Q2 2023

Jul 10, 2023

SELL
$69.91 - $75.81 $43,274 - $46,926
-619 Reduced 54.54%
516 $37,000
Q1 2023

Apr 13, 2023

BUY
$63.15 - $71.6 $42,184 - $47,828
668 Added 143.04%
1,135 $79,000
Q4 2022

Jan 11, 2023

BUY
$54.21 - $70.44 $10,299 - $13,383
190 Added 68.59%
467 $32,000
Q3 2022

Oct 27, 2022

SELL
$53.02 - $135.75 $12,512 - $32,037
-236 Reduced 46.0%
277 $15,000
Q2 2022

Jul 12, 2022

BUY
$59.26 - $71.14 $5,392 - $6,473
91 Added 21.56%
513 $34,000
Q1 2022

Apr 27, 2022

BUY
$55.72 - $67.12 $8,135 - $9,799
146 Added 52.9%
422 $28,000
Q4 2021

Jan 28, 2022

SELL
$54.02 - $63.83 $1,836 - $2,170
-34 Reduced 10.97%
276 $16,000
Q3 2021

Nov 02, 2021

BUY
$55.56 - $60.79 $4,611 - $5,045
83 Added 36.56%
310 $19,000
Q2 2021

Aug 05, 2021

BUY
$48.42 - $60.18 $1,210 - $1,504
25 Added 12.38%
227 $14,000
Q1 2021

Apr 26, 2021

BUY
$47.16 - $54.44 $2,405 - $2,776
51 Added 33.77%
202 $10,000
Q2 2020

Jul 21, 2020

BUY
$43.1 - $55.31 $6,508 - $8,351
151 New
151 $8,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $221B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Financial Management Professionals, Inc. Portfolio

Follow Financial Management Professionals, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Management Professionals, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Management Professionals, Inc. with notifications on news.